Visiopharm Corp is a leading provider of AI-driven precision pathology software solutions for research and diagnostics. With over 20 years of experience working with pathologists and research scientists, their unique software combines deep learning AI with extensive knowledge to deliver accurate and versatile tissue analysis. Whether it's developing next-generation therapies or matching therapies with the right patients, Visiopharm ensures the quality needed to stay ahead.
Visiopharm offers a range of products and services, including Oncotopix Discovery for tissue research, Phenoplex for multiplexed image analysis, and CE-IVD APPs and workflows for diagnostic decision support. Their standardized digital workflows and modular analysis units in the APP Center streamline pathology workflows and reduce development time. With a commitment to advancing quality assurance in immunohistochemistry, Visiopharm is at the forefront of revolutionizing tissue analysis through AI-driven solutions.
Generated from the website